论文部分内容阅读
随着分子生物学、生物化学、分子遗传学、免疫学与分子药理学等学科的进展,临床血液病的研究亦有很大发展。兹将近年来有关贫血方面的进展,综合如下:缺铁性贫血:本病在世界任何地方均可见到,无论城市和农村都很常见,约占贫血病例的2/3,约占全世界人口的10～20%。亚洲发病率较欧洲为高,美国也不少见,尤以西北部多见。以12岁以下儿童、12～18岁的妇女与育龄妇女最多。为何12～18岁的妇女发病高,目前尚无很好的解释。近年来,将缺铁性贫血分为:缺铁现象、红细胞生成的缺铁期与缺铁性
With advances in molecular biology, biochemistry, molecular genetics, immunology and molecular pharmacology and other disciplines, there has also been a great development in the study of clinical blood diseases. The progress made in recent years on anemia is summarized as follows: Iron deficiency anemia: This disease is found anywhere in the world, both in urban and rural areas, accounting for about two-thirds of anemic cases, accounting for about the world’s population 10 ~ 20%. The incidence in Asia is higher than in Europe, and the United States is not uncommon, especially in the northwest. Children under 12 years of age, women aged 12 to 18 years and women of childbearing age most. Why 12 to 18-year-old women with high incidence, there is no good explanation. In recent years, the iron deficiency anemia is divided into: iron deficiency, erythropoiesis, iron deficiency and iron deficiency